Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Gould

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|December 27, 2021
Long-Term Infectivity of Chikungunya Virus Stored in the Dark at 4°CLaura Pezzi, Odile Py, Magali Gilles, et al.
Nature|February 27, 2018
Two chemically similar stellar overdensities on opposite sides of the plane of the Galactic diskMaria Bergemann, Branimir Sesar, Judith G Cohen, et al.
American Journal of Rhinology & Allergy|June 22, 2016
Medical therapy versus sinus surgery by using balloon sinus dilation technology: A prospective multicenter studySpencer C Payne, Pablo Stolovitzky, Neelesh Mehendale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2024
Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for GlioblastomaKarl J Habashy, Crismita Dmello, Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2023
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided AnalysisVíctor A Arrieta, Johnny Duerinck, Kirsten B Burdett, et al.
JCI Insight|December 26, 2024
Endothelial response to blood-brain barrier disruption in the human brainAndrew Gould, Yu Luan, Ye Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and GlioblastomaCrismita Dmello, Aarón Sonabend, Victor A Arrieta, et al.
The Lancet. Oncology|May 4, 2023
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trialAdam M Sonabend, Andrew Gould, Christina Amidei, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
MAPK/ERK signaling in gliomas modulates interferon responses, T cell recruitment, microglia phenotype, and immune checkpoint blockade efficacyKwang-Soo Kim, Junyi Zhang, Víctor A Arrieta, et al.
Nature Communications|June 25, 2026
Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responsesKwang-Soo Kim, Junyi Zhang, Víctor A Arrieta, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|December 27, 2021
Long-Term Infectivity of Chikungunya Virus Stored in the Dark at 4°CLaura Pezzi, Odile Py, Magali Gilles, et al.
Nature|February 27, 2018
Two chemically similar stellar overdensities on opposite sides of the plane of the Galactic diskMaria Bergemann, Branimir Sesar, Judith G Cohen, et al.
American Journal of Rhinology & Allergy|June 22, 2016
Medical therapy versus sinus surgery by using balloon sinus dilation technology: A prospective multicenter studySpencer C Payne, Pablo Stolovitzky, Neelesh Mehendale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2024
Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for GlioblastomaKarl J Habashy, Crismita Dmello, Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2023
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided AnalysisVíctor A Arrieta, Johnny Duerinck, Kirsten B Burdett, et al.
JCI Insight|December 26, 2024
Endothelial response to blood-brain barrier disruption in the human brainAndrew Gould, Yu Luan, Ye Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and GlioblastomaCrismita Dmello, Aarón Sonabend, Victor A Arrieta, et al.
The Lancet. Oncology|May 4, 2023
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trialAdam M Sonabend, Andrew Gould, Christina Amidei, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
MAPK/ERK signaling in gliomas modulates interferon responses, T cell recruitment, microglia phenotype, and immune checkpoint blockade efficacyKwang-Soo Kim, Junyi Zhang, Víctor A Arrieta, et al.
Nature Communications|June 25, 2026
Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responsesKwang-Soo Kim, Junyi Zhang, Víctor A Arrieta, et al.
Pageof 3